Matcha vs Modafinil for energy
Short answer: For energy, more users report improvement with Matcha — 100% of 29 reports, versus 93% of 485 for Modafinil.
Matcha has 6 meta-analyses and 14 randomized trials on PubMed; Modafinil has 155 and 297.
Based on 104 reports about Matcha and 1,613 about Modafinil. Not medical advice.
| Matcha Supplement | Modafinil Medication | |
|---|---|---|
| Users say it helped | 80%helped48 reports · medium confidence | 50%helped936 reports · high confidence |
| Verdict | Mostly positive | Mixed |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 6 / 14 | 155 / 297 |
| Mainly used for | ||
| Focus % reporting improvement | 100% (18) | 86% (689) |
| Energy % reporting improvement | 100% (29) | 93% (485) |
| Mood % reporting improvement | 100% (9) | 64% (125) |
| Anxiety % reporting improvement | 85% (13) | 30% (87) |
| Sleep % reporting improvement | — | 21% (94) |
| Common side effects | nausea, stomach issues, high fluoride, stomach discomfort | insomnia, anxiety, headache, tolerance |
| Typical dose reported | 1.2 g / daily | Not listed |
Menon et al. model was able to predict well for our clinical data where it had the relative mean prediction error percentage ≤ 20%, relative median absolute prediction error ≤ 30% and relative root mean square error close to zero. Based on this final model, we proposed a dosing nomogram for various weight groups, which could potentially help to maintain the trough concentrations in the therapeutic range.
Cancer Chemother Pharmacol, 2024 ↗“I drank 0.125-0.25 cup of matcha every hour and was able to have sustained, mild energy throughout the day. No peaks and valleys.”
Our findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for the short-term treatment of ADHD. New research should be funded urgently to assess long-term effects of these drugs.
Lancet Psychiatry, 2018 ↗“It did make me focused and alert. I was working two jobs at the time and needed every ounce of energy I could muster.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate